Class 2 Medicines Recall: Mollipaxin 100mg capsules

Class 2 Medicines Recall: Mollipaxin 100mg capsules (one batch)

Winthrop Pharmaceuticals UK Limited (trading as Zentiva) is conducting a precautionary recall of a single batch of Mollipaxin 100 mg capsules due to a potential issue with the metal detector during manufacture of the batch (EL(18) A/01).

Update: First published.

For further information on this published alert click here.

 

Recommended

RPS: a “scandal” not to make best use of pharmacists

The RPS’s Sandra Gidley has said it would be “nothing short of a scandal” if health services did not make best use...

Survey: Tell us your views about pharmacy in 2018

Pharmacy Magazine is updating our 2017 research looking at the key issues affecting the sector – and we want to hear y...